The efficacy/cost ratio of new therapy. What is the physician's fiduciary responsibility?
Pingleton
S K
SK
D000328:Adult; D003362:Cost-Benefit Analysis; D003550:Cystic Fibrosis / Q000188:drug therapy; D003850:Deoxyribonuclease I; D003851:Deoxyribonucleases / Q000191:economics* / Q000627:therapeutic use*; D016527:Drug Costs; D006801:Humans; D010817:Physician-Patient Relations; D011994:Recombinant Proteins / Q000191:economics* / Q000627:therapeutic use*; D012941:Social Responsibility
D011994:Recombinant Proteins; D003851:Deoxyribonucleases; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I